Citations

Clear

510 citation(s) found for "Link, Michael".

Superior Semicircular Canal Dehiscence: Assessing the Spectrum of Clinical Features and Surgical Outcomes in a Longitudinally Followed up Cohort of 34 Patients
Cohen-Cohen, Salomón , Perry, Avital , Graffeo, Christopher S. , Driscoll, Colin L. W., Link, Michael

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | March 6, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0039-1679550 Get It

Stereotactic Radiosurgery for Glomus Jugulare Tumors: Long-Term Tumor Control Using 3D Volumetric Tumor Analysis
Patel, Neil V. , Carlson, Matthew L. , Pollock, Bruce E. , Driscoll, Colin L. W., Neff, Brian, Foote, Robert L. , Lohse, Christine M. , Link, Michael P., Neff, Brian A., Link, Michael

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | March 6, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0039-1679516 Get It

Does a Period of Observation before Treatment Lead to Worse Quality of Life in Vestibular Schwannoma Patients?
Link, Michael J. , Lohse, Christine M. , Castner, Marina L., Tombers, Nicole M. , Celda, María Peris, Driscoll, Colin L. W., Carlson, Matthew L.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | March 6, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0039-1679488 Get It

Sphenoorbital Meningiomas: Tumor Control, Visual Function, and Cranial Nerve Outcomes in a Large, Longitudinally followed Single-Surgeon Cohort
Casabella, Amanda M., Perry, Avital , Graffeo, Christopher S. , Garrity, James, Link, Michael J. , Kiyofuji, Satoshi

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | March 6, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0039-1679450 Get It

Induction Chemotherapy before Surgical Resection for Patients Presenting with Unresectable Esthesioneuroblastoma
Marinelli, John P. , Janus, Jeffrey R. , Link, Michael J., Choby, Garret , Miller, Kevin, Chintakuntlawar, Ashish V. , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | March 6, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0039-1679417 Get It

Retrosigmoid Approach for Resection of Medium-Sized Vestibular Schwannoma
Link, Michael J. , Driscoll, Colin L. W., Feng, Yening , Peris‐Celda, Maria , Graffeo, Christopher S.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | March 4, 2019 | Volume: 80 | Issue: S 03 | Pages: S284-S284

10.1055/s-0039-1677848 | PMID 31143591 Get It

Objectives This video was aimed to describe the relevant anatomy and key surgical steps of retrosigmoid approach for gross total resection of a medium-sized vestibular schwannoma (VS). Design The procedure is described in a surgical instructional video. Setting The surgery took place at a tertiary skull base referral center. Participant Patient is a 63-year-old woman who reported with nonserviceable hearing (Pure Tone Average 60 dB Hearing level, Word Recognition Score 45%), occasional tinnitus, and a VS in the left cerebellopontine angle (CPA), extending into internal auditory canal (IAC), measuring 1.7 cm parallel to the petrous temporal bone. Main Outcome Measures The VS was resected by retrosigmoid approach. Results The surgery results gross total resection of the VS with postoperative House–Brackmann grade 1 facial nerve function and no postoperative complications. Conclusion The retrosigmoid approach is a good strategy to remove VS involving the CPA and the IAC.The link to the video can be found at: https://youtu.be/B6K_UkrKitg.
Retrosigmoid Approach for Resection of Large Cystic Vestibular Schwannoma
Link, Michael J. , Driscoll, Colin L. W., Feng, Yening , Peris‐Celda, Maria , Graffeo, Christopher S.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 27, 2019 | Volume: 80 | Issue: S 03 | Pages: S285-S285

10.1055/s-0039-1677850 | PMID 31143592 Get It

Objectives This video was aimed to describe the surgical indications, relevant anatomy, and surgical steps of retrosigmoid approach for resection of a large cystic vestibular schwannoma (VS). Design The operative steps are described in a surgical instructional video. Setting The surgery took place at a tertiary skull base referral center. Participant Patient is a 62-year-old man who reported with right sided profound hearing loss with no word recognition, progressive dizziness and tinnitus, excruciating burning pain in the V2 distribution of right trigeminal nerve, wide-based gait, and a right cerebellopontine angle (CPA) cystic VS measuring 3.3 cm. Main Outcome Measures The large cystic VS was resected through retrosigmoid approach. Results The surgery resulted in removal of the large cystic VS with initial delayed facial weakness that completely resolved (House Brackmann grade 1) by 3 month follow-up. The patient had no other postoperative complications and is convalescing well from the procedure. Conclusion Cystic VS presents some unique challenges compared with their solid counterparts. The cystic tumor capsule may be very adherent to the adjacent structures, and distinguishing thin cyst walls from the arachnoid of the CPA, can be quite challenging. The retrosigmoid approach provides adequate surgical exposure for VS tumor resection.The link to the video can be found at: https://youtu.be/sFNvRWG465Q.
Glioblastoma of the cerebellopontine angle and internal auditory canal mimicking a peripheral nerve sheath tumor: case report
Prummer, Christoph M., Graffeo, Christopher S. , Peris‐Celda, Maria , Driscoll, Colin L. W., Link, Michael J. , Takami, Hirokazu , Giannini, Caterina

Mayo Clinic

Journal of Neurosurgery | February 27, 2019 | Volume: 131 | Issue: 6 | Pages: 1835-1839

10.3171/2018.8.jns181702 | PMID 30579279 Get It

Glioblastoma (GBM) of the internal auditory canal (IAC) is exceedingly rare, with only 3 prior cases reported in the literature. The authors present the fourth case of cerebellopontine angle (CPA) and IAC GBM, and the first in which the lesion mimicked a vestibular schwannoma (VS) early in its natural history. A 55-year-old man presented with tinnitus, hearing loss, and imbalance. MRI identified a left IAC/CPA lesion measuring 8 mm, most consistent with a benign VS. Over the subsequent 4 months he developed facial weakness. The tumor grew remarkably to 24 mm and surgery was recommended; the main preoperative diagnosis was malignant peripheral nerve sheath tumor (MPNST). Resection proceeded via a translabyrinthine approach with resection of cranial nerves VII and VIII, followed by facial-hypoglossal nerve anastomosis. Intraoperative frozen section suggested malignant spindle cell neoplasm, but final histopathological and molecular testing confirmed the lesion to be a GBM. The authors report the first case in which absence of any brainstem interface effectively excluded a primary parenchymal tumor, in particular GBM, from the differential diagnosis. Given the dramatic differences in treatment and prognoses between malignant glioma and MPNST, this case emphasizes the importance of surgical intervention on an aggressively growing lesion, which provides both the best probability of local control and the critical tissue diagnosis.
Influence of Selection Bias in Survey Studies Derived From a Patient-Focused Organization: A Comparison of Response Data From a Single Tertiary Care Center and the Acoustic Neuroma Association
Prummer, Christoph M., Kerezoudis, Panagiotis , Tombers, Nicole M. , Peris‐Celda, Maria , Link, Michael J. , Carlson, Matthew L.

Mayo Clinic

Otology & Neurotology | February 26, 2019 | Volume: 40 | Issue: 4 | Pages: 504-510

10.1097/mao.0000000000002151 | PMID 30870367 Get It

Background: The Acoustic Neuroma Association (ANA) is a national, nonprofit organization, focused on the education and support of patients with vestibular schwannoma (VS). The aim of the present study is to characterize the profile of ANA survey respondents and compare them with non-ANA patients evaluated at a single tertiary academic referral center to investigate the potential influence of selection bias. Methods: A prospectively maintained VS quality-of-life (QOL) database, comprised of patients evaluated at the authors’ center and members of the ANA, was queried. Demographic variables, patient-reported symptoms and tumor characteristics, as well as patient-reported outcome scores were captured. Health-related QOL was evaluated using the disease-specific Penn Acoustic Neuroma QOL (PANQOL) questionnaire. Multivariable regression models were fitted for PANQOL domain and total scores as well as satisfaction with treatment adjusting for baseline demographics, symptoms, and PANQOL scores. Results: A total of 1,060 patients (802 [76%] ANA respondents) were analyzed. Overall, ANA patients were slightly younger (mean age: 59 vs 60 yr, p = 0.145), more likely to be women (72 vs 55%, p < 0.001), and had a larger tumor size (overall p < 0.001). Furthermore, a significantly higher proportion of ANA patients were more likely to undergo microsurgery (57 vs 21%) or radiation (21 vs 8%) and less likely to be managed with observation (16 vs 65%, overall p < 0.001). A significantly higher proportion of ANA patients reported hearing loss (95 vs 88%, p < 0.001), tinnitus (80 vs 73%, p = 0.034), dizziness (78 vs 64%, p < 0.001), headache (56 vs 45% p = 0.003), and facial paralysis (37 vs 12%, p < 0.001). On multivariable analysis, ANA respondents exhibited significantly lower PANQOL scores for hearing (OR: 0.47, 95% CI: 0.35–0.64, p < 0.001), balance (OR: 0.51, 95% CI: 0.38–0.70, p < 0.001), pain (OR: 0.63, 95% CI: 0.46–0.86, p = 0.004), facial function (OR: 0.58, 95% CI: 0.42–0.80, p = 0.001), energy (OR: 0.44, 95% CI: 0.32–0.59, p < 0.001), anxiety (OR: 0.54, 95% CI: 0.40–0.74, p < 0.001), general (OR: 0.72, 95% CI: 0.53–0.98, p = 0.03), and total QOL (OR: 0.40, 95% CI: 0.30–0.55, p < 0.001). No statistically significant difference was seen with regard to treatment satisfaction. To determine the true clinical relevance of these differences, the two groups were compared using the minimal clinically important difference (MCID) for each domain. MCID is defined as the smallest difference in score in the domain of interest that patients perceive as important, either beneficial or harmful. The domains for hearing, balance, energy, anxiety, and total QOL reached their respective MCID thresholds, indicating that the ANA cohort has QOL scores that are clinically, perceptually worse for these domains compared to the non-ANA group. Conclusion: These data help delineate some of the inherent limitations and biases associated with survey studies incorporating data from national patient support organizations. The population profile of ANA survey respondents likely differs significantly from the greater population of patients with VS that may be encountered at a tertiary referral center.
Novel rodent model for simulation of sylvian fissure dissection and cerebrovascular bypass under subarachnoid hemorrhage conditions: technical note and timing study
Perry, Avital , Graffeo, Christopher S. , Anding, William J., Link, Michael J., Rangel-Castilla, Leonardo , Carlstrom, Lucas P. , Rangel-Castilla, Leonardo

Mayo Clinic

Neurosurgical Focus | February 26, 2019 | Volume: 46 | Issue: 2 | Pages: E17

10.3171/2018.11.focus18533 | PMID 30717047 Get It

OBJECTIVE Sylvian fissure dissection following subarachnoid hemorrhage (SAH) is a challenging but fundamental skill in microneurosurgery, and one that has become increasingly difficult to develop during residency, given the overarching management trends. The authors describe a novel rodent model for simulation of sylvian fissure dissection and cerebrovascular bypass under SAH conditions. METHODS A standardized microvascular anastomosis model comprising rat femoral arteries and veins was used for the experimental framework. In the experimental protocol, following exposure and skeletonization of the vessels, extensive, superficial (1- to 2-mm) soft-tissue debridement was conducted and followed by wound closure and delayed reexploration at intervals of 7, 14, and 28 days. Two residents dissected 1 rat each per time point (n = 6 rats), completing vessel skeletonization followed by end-to-end artery/vein anastomoses. Videos were reviewed postprocedure to assess scar score and relative difficulty of dissection by blinded raters using 4-point Likert scales. RESULTS At all time points, vessels were markedly invested in friable scar, and exposure was subjectively assessed as a reasonable surrogate for sylvian fissure dissection under SAH conditions. Scar score and relative difficulty of dissection both indicated 14 days as the most challenging time point. CONCLUSIONS The authors’ experimental model of femoral vessel skeletonization, circumferential superficial soft-tissue injury, and delayed reexploration provides a novel approximation of sylvian fissure dissection and cerebrovascular bypass under SAH conditions. The optimal reexploration interval appears to be 7–14 days. To the authors’ knowledge, this is the first model of SAH simulation for microsurgical training, particularly in a live animal system.